Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 7/2012

01.07.2012 | Original Article

Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway

verfasst von: Heriberto Prado-Garcia, Susana Romero-Garcia, Jorge Morales-Fuentes, Dolores Aguilar-Cazares, Jose Sullivan Lopez-Gonzalez

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Lung cancer is the second most common form of cancer and the leading cause of cancer death worldwide. Pleural effusions, containing high numbers of mononuclear and tumor cells, are frequent in patients with advanced stages of lung cancer. We reported that in pleural effusions from primary lung cancer, the CD8+ T cell subpopulation, and particularly the terminally differentiated subset, is reduced compared to that of non-malignant effusions. We analyzed the participation of activation-induced cell death (AICD) and extrinsic pathways (type I or II) as mechanisms for the decrease in pleural effusion CD8+ T cell subpopulation. Pleural effusion or peripheral blood CD4+ and CD8+ T cells, from lung cancer patients, were stimulated with anti-CD3 antibody and analyzed for (a) apoptosis by annexin-V-binding and TUNEL assay, (b) transcript levels of Fas ligand (FasL) and TRAIL by real-time RT–PCR, (c) expression of FasL and TRAIL, measured as integrated mean fluorescence intensities (iMFI) by flow cytometry, (d) expression of Bcl-2 and BIM molecules, measured as MFI, and (e) apoptosis inhibition using caspase-8 and -9 inhibitors. Pleural effusion CD8+ T cells, but not CD4+ T cells, from cancer patients underwent AICD. Blocking FasL/Fas pathway protected from AICD. Upregulation of FasL and TRAIL expressions was found in pleural effusion CD8+ T cells, which also showed a subset of Bcl-2 low cells. In memory CD8+ T cells, AICD depended on both extrinsic and intrinsic apoptotic pathways. Hence, in the pleural space of lung cancer patients, AICD might compromise the antitumor function of CD8+ T cells.
Literatur
1.
Zurück zum Zitat Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29S–55SPubMedCrossRef Alberg AJ, Ford JG, Samet JM (2007) Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:29S–55SPubMedCrossRef
2.
3.
Zurück zum Zitat Atanackovic D, Block A, de Weerth A, Faltz C, Hossfeld DK, Hegewisch-Becker S (2004) Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res 10:2600–2608PubMedCrossRef Atanackovic D, Block A, de Weerth A, Faltz C, Hossfeld DK, Hegewisch-Becker S (2004) Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res 10:2600–2608PubMedCrossRef
4.
Zurück zum Zitat Pace E, Bruno TF, Berenger B, Mody CH, Melis M, Ferraro M, Tipa A, Bruno A, Profita M, Bonsignore G, Gjomarkaj M (2007) Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space. Immunology 121:427–436PubMedCrossRef Pace E, Bruno TF, Berenger B, Mody CH, Melis M, Ferraro M, Tipa A, Bruno A, Profita M, Bonsignore G, Gjomarkaj M (2007) Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space. Immunology 121:427–436PubMedCrossRef
5.
Zurück zum Zitat Prado-Garcia H, Aguilar-Cazares D, Flores-Vergara H, Mandoki JJ, Lopez-Gonzalez JS (2005) Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 47:361–371PubMedCrossRef Prado-Garcia H, Aguilar-Cazares D, Flores-Vergara H, Mandoki JJ, Lopez-Gonzalez JS (2005) Effector, memory and naïve CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 47:361–371PubMedCrossRef
6.
Zurück zum Zitat Broderick L, Brooks SP, Takita H, Baer AN, Bernstein JM, Bankert RB (2006) IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin Immunol 118:159–169PubMedCrossRef Broderick L, Brooks SP, Takita H, Baer AN, Bernstein JM, Bankert RB (2006) IL-12 reverses anergy to T cell receptor triggering in human lung tumor-associated memory T cells. Clin Immunol 118:159–169PubMedCrossRef
7.
Zurück zum Zitat Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother 53:1146–1152PubMedCrossRef Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Immunother 53:1146–1152PubMedCrossRef
8.
Zurück zum Zitat Maher S, Toomey D, Condron C, Bouchier-Hayes D (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilige and tumour counterattack. Immunol Cell Biol 80:131–137PubMedCrossRef Maher S, Toomey D, Condron C, Bouchier-Hayes D (2002) Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilige and tumour counterattack. Immunol Cell Biol 80:131–137PubMedCrossRef
9.
Zurück zum Zitat Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL (2009) Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol 183:3720–3730PubMedCrossRef Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL (2009) Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol 183:3720–3730PubMedCrossRef
10.
Zurück zum Zitat Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8:2553–2562PubMed Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL (2002) Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res 8:2553–2562PubMed
11.
Zurück zum Zitat Kuss I, Donnenberg AD, Gooding W, Whiteside TL (2003) Effector CD8+ CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck. Br J Cancer 88:223–230PubMedCrossRef Kuss I, Donnenberg AD, Gooding W, Whiteside TL (2003) Effector CD8+ CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck. Br J Cancer 88:223–230PubMedCrossRef
12.
13.
Zurück zum Zitat Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Morales-Fuentes J, Lopez-Gonzalez JS (2008) Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunol Immunother 57:325–336PubMedCrossRef Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Morales-Fuentes J, Lopez-Gonzalez JS (2008) Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunol Immunother 57:325–336PubMedCrossRef
14.
Zurück zum Zitat Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532–542PubMedCrossRef Krammer PH, Arnold R, Lavrik IN (2007) Life and death in peripheral T cells. Nat Rev Immunol 7:532–542PubMedCrossRef
15.
Zurück zum Zitat Gorak-Stolinska P, Truman JP, Kemeny DM, Noble A (2001) Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha. J Leuk Biol 70:756–766 Gorak-Stolinska P, Truman JP, Kemeny DM, Noble A (2001) Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha. J Leuk Biol 70:756–766
16.
Zurück zum Zitat Bouillet P, O’Reilly LA (2009) CD95, BIM and T cell homeostasis. Nat Rev Immunol 9:514–519PubMedCrossRef Bouillet P, O’Reilly LA (2009) CD95, BIM and T cell homeostasis. Nat Rev Immunol 9:514–519PubMedCrossRef
17.
Zurück zum Zitat Restifo NP (2000) Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med 6:493–495PubMedCrossRef Restifo NP (2000) Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape. Nat Med 6:493–495PubMedCrossRef
18.
Zurück zum Zitat Zaks TZ, Chappell DB, Rosenberg SA, Restifo NP (1999) Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J Immunol 162:3273–3279PubMed Zaks TZ, Chappell DB, Rosenberg SA, Restifo NP (1999) Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J Immunol 162:3273–3279PubMed
19.
Zurück zum Zitat Li JH, Rosen D, Sondel P, Berke G (2002) Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology 105:267–277PubMedCrossRef Li JH, Rosen D, Sondel P, Berke G (2002) Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells. Immunology 105:267–277PubMedCrossRef
20.
Zurück zum Zitat Radoja S, Saio M, Frey AB (2001) CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol 166:6074–6083PubMed Radoja S, Saio M, Frey AB (2001) CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. J Immunol 166:6074–6083PubMed
21.
Zurück zum Zitat Friedlein G, El Hage F, Vergnon I, Richon C, Saulnier P, Lécluse Y, Caignard A, Boumsell L, Bismuth G, Chouaib S, Mami-Chouaib F (2007) Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J Immunol 178:6821–6827PubMed Friedlein G, El Hage F, Vergnon I, Richon C, Saulnier P, Lécluse Y, Caignard A, Boumsell L, Bismuth G, Chouaib S, Mami-Chouaib F (2007) Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J Immunol 178:6821–6827PubMed
22.
Zurück zum Zitat Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A (2003) CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res 63:7475–7482PubMed Gati A, Guerra N, Gaudin C, Da Rocha S, Escudier B, Lécluse Y, Bettaieb A, Chouaib S, Caignard A (2003) CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res 63:7475–7482PubMed
23.
Zurück zum Zitat Mueller YM, Makar V, Bojczuk PM, Witek J, Katsikis PD (2003) IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. Int Immunol 15:49–58PubMedCrossRef Mueller YM, Makar V, Bojczuk PM, Witek J, Katsikis PD (2003) IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells. Int Immunol 15:49–58PubMedCrossRef
24.
Zurück zum Zitat Albers AE, Schaefer C, Visus C, Gooding W, DeLeo AB, Whiteside TL (2009) Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer. Head Neck 31:773–781PubMedCrossRef Albers AE, Schaefer C, Visus C, Gooding W, DeLeo AB, Whiteside TL (2009) Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer. Head Neck 31:773–781PubMedCrossRef
25.
Zurück zum Zitat Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843–850PubMedCrossRef Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, Roederer M, Seder RA (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843–850PubMedCrossRef
26.
Zurück zum Zitat Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N (1994) Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201–1208PubMed Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N (1994) Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201–1208PubMed
27.
Zurück zum Zitat Fas SC, Baumann S, Krueger A, Frey CR, Schulze-Bergkamen H, Brenner D, Stumpf C, Kappes K, Krammer PH (2006) In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis. Eur J Immunol 36:2894–2903PubMedCrossRef Fas SC, Baumann S, Krueger A, Frey CR, Schulze-Bergkamen H, Brenner D, Stumpf C, Kappes K, Krammer PH (2006) In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis. Eur J Immunol 36:2894–2903PubMedCrossRef
28.
Zurück zum Zitat Bosque A, Pardo J, Martínez-Lorenzo MJ, Iturralde M, Marzo I, Piñeiro A, Alava MA, Naval J, Anel A (2005) Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c-FLIP, Bim, or Bcl-x isoform expression. J Leuk Biol 77:568–578CrossRef Bosque A, Pardo J, Martínez-Lorenzo MJ, Iturralde M, Marzo I, Piñeiro A, Alava MA, Naval J, Anel A (2005) Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c-FLIP, Bim, or Bcl-x isoform expression. J Leuk Biol 77:568–578CrossRef
29.
Zurück zum Zitat Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009) Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 183:1120–1132PubMedCrossRef Petrovas C, Chaon B, Ambrozak DR, Price DA, Melenhorst JJ, Hill BJ, Geldmacher C, Casazza JP, Chattopadhyay PK, Roederer M, Douek DC, Mueller YM, Jacobson JM, Kulkarni V, Felber BK, Pavlakis GN, Katsikis PD, Koup RA (2009) Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection. J Immunol 183:1120–1132PubMedCrossRef
30.
Zurück zum Zitat Okamoto M, Hasegawa Y, Hara T, Hashimoto N, Imaizumi K, Shimokata K, Kawabe T (2005) T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 128:4030–4035PubMedCrossRef Okamoto M, Hasegawa Y, Hara T, Hashimoto N, Imaizumi K, Shimokata K, Kawabe T (2005) T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 128:4030–4035PubMedCrossRef
31.
Zurück zum Zitat Duncan SR, Elias DJ, Roglic M, Pekny KW, Theofilopoulos AN (1997) T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer. Hum Immunol 53:39–48PubMedCrossRef Duncan SR, Elias DJ, Roglic M, Pekny KW, Theofilopoulos AN (1997) T-cell receptor biases and clonal proliferations in blood and pleural effusions of patients with lung cancer. Hum Immunol 53:39–48PubMedCrossRef
32.
Zurück zum Zitat Srikrishna G, Freeze HH (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11:615–628PubMed Srikrishna G, Freeze HH (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11:615–628PubMed
33.
Zurück zum Zitat Martinez-Lorenzo MJ, Anel A, Gamen S, Monleon I, Lasierra P, Larrad L, Pineiro A, Alava MA, Naval J (1999) Activated human T cell release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 163:1274–1281PubMed Martinez-Lorenzo MJ, Anel A, Gamen S, Monleon I, Lasierra P, Larrad L, Pineiro A, Alava MA, Naval J (1999) Activated human T cell release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol 163:1274–1281PubMed
34.
Zurück zum Zitat Boudet F, Lecoeur H, Gougeon ML (1996) Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156:2282–2293PubMed Boudet F, Lecoeur H, Gougeon ML (1996) Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection. J Immunol 156:2282–2293PubMed
35.
Zurück zum Zitat Lecoeur H, Ledru E, Gougeon ML (1998) A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes. J Immunol Methods 217:11–26PubMedCrossRef Lecoeur H, Ledru E, Gougeon ML (1998) A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes. J Immunol Methods 217:11–26PubMedCrossRef
36.
Zurück zum Zitat Yano T, Fukuyama Y, Yokoyama H, Takai E, Tanaka Y, Asoh H, Ichinose Y (1996) Interleukin-2 receptors in pulmonary adenocarcinoma tissue. Lung Cancer 16:13–19PubMedCrossRef Yano T, Fukuyama Y, Yokoyama H, Takai E, Tanaka Y, Asoh H, Ichinose Y (1996) Interleukin-2 receptors in pulmonary adenocarcinoma tissue. Lung Cancer 16:13–19PubMedCrossRef
37.
Zurück zum Zitat Barker BR, Parvani JG, Meyer D, Hey AS, Skak K, Letvin NL (2007) IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. J Immunol 179:3596–3603PubMed Barker BR, Parvani JG, Meyer D, Hey AS, Skak K, Letvin NL (2007) IL-21 induces apoptosis of antigen-specific CD8+ T lymphocytes. J Immunol 179:3596–3603PubMed
38.
Zurück zum Zitat Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK (2006) Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors. J Immunol 177:6962–6973PubMed Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK (2006) Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors. J Immunol 177:6962–6973PubMed
39.
Zurück zum Zitat Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I (1999) Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol 163:1315–1320PubMed Inaba M, Kurasawa K, Mamura M, Kumano K, Saito Y, Iwamoto I (1999) Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells. J Immunol 163:1315–1320PubMed
40.
Zurück zum Zitat Batra RK, Lin Y, Sharma S, Dohadwala M, Luo J, Pold M, Dubinett SM (2003) Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism. Cancer Res 63:642–646PubMed Batra RK, Lin Y, Sharma S, Dohadwala M, Luo J, Pold M, Dubinett SM (2003) Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism. Cancer Res 63:642–646PubMed
41.
Zurück zum Zitat Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS (2008) Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways. J Immunol 180:4687–4696PubMed Das T, Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Kudo D, Biswas K, Bukowski RM, Finke JH, Tannenbaum CS (2008) Renal cell carcinoma tumors induce T cell apoptosis through receptor-dependent and receptor-independent pathways. J Immunol 180:4687–4696PubMed
42.
Zurück zum Zitat Spooner R, Yilmaz O (2011) The role of reactive-oxygen-species in microbial persistence and inflammation. Int J Mol Sci 12:334–352PubMedCrossRef Spooner R, Yilmaz O (2011) The role of reactive-oxygen-species in microbial persistence and inflammation. Int J Mol Sci 12:334–352PubMedCrossRef
43.
Zurück zum Zitat Williams MS, Noguchi S, Henkart PA, Osawa Y (1998) Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 161:6526–6531PubMed Williams MS, Noguchi S, Henkart PA, Osawa Y (1998) Nitric oxide synthase plays a signaling role in TCR-triggered apoptotic death. J Immunol 161:6526–6531PubMed
44.
Zurück zum Zitat Norell H, Martins da Palma T, Lesher A, Kaur N, Mehrotra M, Naga OS, Spivey N, Olafimihan S, Chakraborty NG, Voelkel-Johnson C, Nishimura MI, Mukherji B, Mehrotra S (2009) Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27–35)-reactive T cells from activation-induced cell death. Cancer Res 169:6282–6289CrossRef Norell H, Martins da Palma T, Lesher A, Kaur N, Mehrotra M, Naga OS, Spivey N, Olafimihan S, Chakraborty NG, Voelkel-Johnson C, Nishimura MI, Mukherji B, Mehrotra S (2009) Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27–35)-reactive T cells from activation-induced cell death. Cancer Res 169:6282–6289CrossRef
45.
Zurück zum Zitat Takahashi A, Hanson MG, Norell HR, Havelka AM, Kono K, Malmberg KJ, Kiessling RV (2005) Preferential cell death of CD8+ effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress. J Immunol 174:6080–6087PubMed Takahashi A, Hanson MG, Norell HR, Havelka AM, Kono K, Malmberg KJ, Kiessling RV (2005) Preferential cell death of CD8+ effector memory (CCR7-CD45RA-) T cells by hydrogen peroxide-induced oxidative stress. J Immunol 174:6080–6087PubMed
46.
Zurück zum Zitat Zarozinski CC, McNally JM, Lohman BL, Daniels KA, Welsh RM (2000) Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol 74:3650–3658PubMedCrossRef Zarozinski CC, McNally JM, Lohman BL, Daniels KA, Welsh RM (2000) Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol 74:3650–3658PubMedCrossRef
47.
Zurück zum Zitat Antoniou KM, Ferdoutsis E, Bouros D (2003) Interferons and their application in the diseases of the lung. Chest 123:209–216PubMedCrossRef Antoniou KM, Ferdoutsis E, Bouros D (2003) Interferons and their application in the diseases of the lung. Chest 123:209–216PubMedCrossRef
48.
Zurück zum Zitat Castagneto B, Zai S, Mutti L, Lazzaro A, Ridolfi R, Piccolini E, Ardizzoni A, Fumagalli L, Valsuani G, Botta M (2001) Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: results of a phase II study on 31 consecutive patients. Lung Cancer 31:303–310PubMedCrossRef Castagneto B, Zai S, Mutti L, Lazzaro A, Ridolfi R, Piccolini E, Ardizzoni A, Fumagalli L, Valsuani G, Botta M (2001) Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: results of a phase II study on 31 consecutive patients. Lung Cancer 31:303–310PubMedCrossRef
49.
Zurück zum Zitat Timoshenko AV, Lan Y, Gabius HJ, Lala PK (2001) Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. Effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer 37:1910–1920PubMedCrossRef Timoshenko AV, Lan Y, Gabius HJ, Lala PK (2001) Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. Effects on tumour growth, capillary leakage and nitric oxide (NO) production. Eur J Cancer 37:1910–1920PubMedCrossRef
Metadaten
Titel
Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway
verfasst von
Heriberto Prado-Garcia
Susana Romero-Garcia
Jorge Morales-Fuentes
Dolores Aguilar-Cazares
Jose Sullivan Lopez-Gonzalez
Publikationsdatum
01.07.2012
Verlag
Springer-Verlag
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 7/2012
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-1165-5

Weitere Artikel der Ausgabe 7/2012

Cancer Immunology, Immunotherapy 7/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.